FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Review Period Set for Prevnar

04/28/2003

Federal Register Notice: FDA has determined the regulatory review period for American Home Products’ Prevnar is 1,910 days f...

Review Period Set for Aromasin

04/28/2003

Federal Register Notice: FDA has determined the regulatory review period for Pharmacia & Upjohn’s Aromasin is 3,153 days for...

New List for Device Standards

04/28/2003

Federal Register Notice: FDA is releasing “Modifications to the List of Recognized Standards, Recognition List Number: 008&#...

Panel to Vote on Dental Product Reclassification

04/28/2003

Federal Register Notice: FDA’s Dental Products Panel of the Medical Devices Advisory Committee will meet 5/22, from 9:30 a.m...

FDA OKs Bayer sNADA for Canine Parasites

04/28/2003

Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a supplemental new animal drug app...

Pennfield Oil ANADA Approved

04/28/2003

Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of an abbreviated new animal drug app...

Advisory Panel Meeting Canceled

04/24/2003

Federal Register Notice: FDA is canceling the meeting of the Peripheral and Central Nervous System Drugs Advisory Committee schedu...

Guidance On Donor Suitability/Safety in SARS Cases

04/23/2003

Federal Register Notice: FDA is making available a document entitled Guidance for Industry: Recommendations for the Assessment of ...

Nominations Sought for FDA Advisory Panels

04/23/2003

Federal Register Notice: FDA is requesting nominations for voting and nonvoting consumer representatives to serve on its advisory ...

Panel to Vote on Ablation Catheter

04/23/2003

Federal Register Notice: FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet 5/29, fr...